CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells - Concepedia

Concepedia

Publication | Open Access

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

DOI Full Paper Access

169

Citations

73

References

2020

Year

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard, Sophie Krumeich, Indrajit Das, Luize G. Lima, Lizeth G. Meza Guzman, Kunlun Li,

Tumor ImmunologyCancer ImmunosurveillanceActivating Receptor Cd226T-regulatory CellImmunologyTumor CellsAutoimmunityCd8+ T CellsImmune Checkpoint InhibitorImmunotherapyMedicineCell Biology

References

	Year	Citations

Page 1

Page 1